Q4 venture financing round up: Ex-Philips molecular dx tech draws in the big bucks
This article was originally published in Clinica
Executive Summary
Following a massive spike in the number of medtech venture financing transactions in Q3, the final quarter of 2011 saw deal volume fall back to levels closer to those recorded in the first half of the year.